Literature DB >> 14623723

Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.

Robert H Dworkin1, Miroslav Backonja, Michael C Rowbotham, Robert R Allen, Charles R Argoff, Gary J Bennett, M Catherine Bushnell, John T Farrar, Bradley S Galer, Jennifer A Haythornthwaite, David J Hewitt, John D Loeser, Mitchell B Max, Mario Saltarelli, Kenneth E Schmader, Christoph Stein, David Thompson, Dennis C Turk, Mark S Wallace, Linda R Watkins, Sharon M Weinstein.   

Abstract

Chronic neuropathic pain, caused by lesions in the peripheral or central nervous system, comes in many forms. We describe current approaches to the diagnosis and assessment of neuropathic pain and discuss the results of recent research on its pathophysiologic mechanisms. Randomized controlled clinical trials of gabapentin, the 5% lidocaine patch, opioid analgesics, tramadol hydrochloride, and tricyclic antidepressants provide an evidence-based approach to the treatment of neuropathic pain, and specific recommendations are presented for use of these medications. Continued progress in basic and clinical research on the pathophysiologic mechanisms of neuropathic pain may make it possible to predict effective treatments for individual patients by application of a pain mechanism-based approach.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623723     DOI: 10.1001/archneur.60.11.1524

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  217 in total

Review 1.  Evidence-based guideline for neuropathic pain interventional treatments: spinal cord stimulation, intravenous infusions, epidural injections and nerve blocks.

Authors:  Angela Mailis; Paul Taenzer
Journal:  Pain Res Manag       Date:  2012 May-Jun       Impact factor: 3.037

2.  Pain management part II: pharmacologic management of chronic orofacial pain.

Authors:  Steven Ganzberg
Journal:  Anesth Prog       Date:  2010

3.  Spinal injection of TNF-α-activated astrocytes produces persistent pain symptom mechanical allodynia by releasing monocyte chemoattractant protein-1.

Authors:  Yong-Jing Gao; Ling Zhang; Ru-Rong Ji
Journal:  Glia       Date:  2010-11-15       Impact factor: 7.452

Review 4.  Chemokines, neuronal-glial interactions, and central processing of neuropathic pain.

Authors:  Yong-Jing Gao; Ru-Rong Ji
Journal:  Pharmacol Ther       Date:  2010-02-01       Impact factor: 12.310

5.  Identification of a vesicular ATP release inhibitor for the treatment of neuropathic and inflammatory pain.

Authors:  Yuri Kato; Miki Hiasa; Reiko Ichikawa; Nao Hasuzawa; Atsushi Kadowaki; Ken Iwatsuki; Kazuhiro Shima; Yasuo Endo; Yoshiro Kitahara; Tsuyoshi Inoue; Masatoshi Nomura; Hiroshi Omote; Yoshinori Moriyama; Takaaki Miyaji
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-18       Impact factor: 11.205

6.  Conceptual Conditioning: Mechanisms Mediating Conditioning Effects on Pain.

Authors:  Marieke Jepma; Tor D Wager
Journal:  Psychol Sci       Date:  2015-09-17

Review 7.  Mechanisms, Predictors, and Challenges in Assessing and Managing Painful Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Grace A Kanzawa-Lee; Robert Knoerl; Clare Donohoe; Celia M Bridges; Ellen M Lavoie Smith
Journal:  Semin Oncol Nurs       Date:  2019-04-30       Impact factor: 2.315

Review 8.  Management of breakthrough pain in patients with cancer.

Authors:  Leeroy William; Rod Macleod
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 9.  Activation of JNK pathway in persistent pain.

Authors:  Yong-Jing Gao; Ru-Rong Ji
Journal:  Neurosci Lett       Date:  2008-03-13       Impact factor: 3.046

10.  Diagnosis and treatment of glossopharyngeal and vagal neuropathies in a patient with laryngopharyngeal reflux.

Authors:  Irina Lokshina; Igor Feinstein; Carole Agin; Robert Katz
Journal:  Anesthesiology       Date:  2008-10       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.